E Fund Management Co. Ltd. Invests $522,000 in Kenvue Inc. $KVUE

E Fund Management Co. Ltd. acquired a new position in Kenvue Inc. (NYSE:KVUE) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 27,323 shares of the company’s stock, valued at approximately $522,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of KVUE. Edmond DE Rothschild Holding S.A. bought a new position in Kenvue in the 2nd quarter worth about $17,199,000. AssuredPartners Investment Advisors LLC acquired a new position in shares of Kenvue during the second quarter worth approximately $625,000. Johnson Financial Group Inc. acquired a new position in shares of Kenvue during the second quarter worth approximately $26,000. Tocqueville Asset Management L.P. bought a new position in Kenvue in the 2nd quarter worth approximately $30,302,000. Finally, NewEdge Wealth LLC bought a new position in Kenvue in the 2nd quarter worth approximately $1,026,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Zacks Research lowered Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 7th. UBS Group lowered their price target on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Tuesday, August 11th. Wall Street Zen downgraded shares of Kenvue from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Barclays upped their price objective on shares of Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Finally, Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 15th. Three research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company. Based on data from MarketBeat.com, Kenvue presently has an average rating of “Hold” and a consensus price target of $19.27.

Kenvue Trading Down 1.1%

Shares of KVUE stock opened at $18.92 on Friday. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $21.78. The company has a quick ratio of 0.71, a current ratio of 1.01 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $36.34 billion, a P/E ratio of 21.75, a P/E/G ratio of 1.37 and a beta of 0.47. The stock has a 50-day simple moving average of $19.04 and a 200 day simple moving average of $18.19.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.31 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.01). The business had revenue of $3.96 billion for the quarter, compared to the consensus estimate of $3.97 billion. Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The business’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter last year, the business posted $0.29 EPS. On average, sell-side analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 26th. Investors of record on Wednesday, August 12th will be paid a dividend of $0.21 per share. This is a boost from Kenvue’s previous quarterly dividend of $0.21. This represents a $0.84 annualized dividend and a yield of 4.4%. The ex-dividend date of this dividend is Wednesday, August 12th. Kenvue’s dividend payout ratio (DPR) is currently 96.55%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.